Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Gold Radiosensitizers for Advanced Proton therapy

Objective

Cancer research efforts nowadays are focused on improving patients’ quality of life through targeted therapies, that decrease adverse effects while improving survival. GRAPE will contribute to this aim by developing therapeutic agents based on biocompatible gold-based nanoparticles (NPs), which will predictably improve proton beam therapy (PBT) outcomes. This will be achieved by not only enhancing the effect of PBT, but also minimizing the off-targeted toxicity that induces damaging of healthy tissues located at the tumor periphery, leading to lower adverse effects related to radiotherapy lack of specificity.
The use of therapeutic nanoplatforms could also be used as a starting point for personalized medicine. The physico-chemical properties of the NPs can be rationally designed according to different needs. Additionally, NPs will be functionalized with active targeting in order to enable selective delivery and accumulation inside glioblastoma multiforme (GBM) cancer cells overexpressing certain markers. After testing NPs selective uptake and toxicity in GBM cells, they will be administered in vivo to assess NP retention by tumor tissue. Then, their therapeutic potential will be assessed in vitro employing a clinical proton therapy equipment. Finally, we will preliminary test their therapeutic effect in vivo, employing oncologic mice models with the same clinical equipment.
Not only GRAPE aims to provide a more personalized therapy for GBM patients, but also for other cancer types. Once the NPs are validated in GBM, their versatility and adaptability will allow the anchoring of other targeting ligands for surface markers specifically overexpressed by other cancer cells, thus expanding overall oncology treatment options.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 120 000,00
Address
CALLE SERRANO 117
28006 MADRID
Spain

See on map

Region
Comunidad de Madrid Comunidad de Madrid Madrid
Activity type
Research Organisations
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Beneficiaries (2)

My booklet 0 0